Digital tool for identifying young people at risk of psychosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop an innovative E-Detection Tool for Emerging Mental Disorders (ENTER) to improve the identification of young individuals experiencing emerging psychosis. Participants aged 12-35 will complete an online questionnaire and short exercises on digital platforms, followed by face-to-face assessments to confirm their mental state. The tool will incorporate epidemiologically-based risk and protective factors to enhance the screening process, leveraging the research team's previous expertise in the field. The goal is to facilitate early detection and intervention for those at risk of psychosis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 12-35 years of age
* Informed consent
* Absence of previous psychotic disorders

Exclusion Criteria:

* \<12 or \>35 years of age
* An existing psychotic disorder

Where it's running

• Glasgow University
  Glasgow, United Kingdom Recruiting
• King's College London
  London, United Kingdom Recruiting

Study contacts

• Study coordinator: Paolo Fuasr Poli, MD PhD
• Email: paolo.fusar-poli@kcl.ac.uk
• Phone: +442078480900

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Examining the effects of combined therapy for schizophrenia

  This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.

  Recruiting at 2 sites University of Toronto · Scarborough Village, Ontario and 1 other locations · NCT05731414

• State Representation in Early Psychosis 2

  This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.

  Recruiting at 2 sites University of Minnesota · Minneapolis, Minnesota and 1 other locations · NCT07834203

• Recovery-oriented suicide prevention for young people at clinical high risk for psychosis

  This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.

  Recruiting at 2 sites University of California, San Diego · Los Angeles, California and 1 other locations · NCT07756567

• Combined brain stimulation and yoga for improving cognition in psychosis

  This study tests whether active brain stimulation plus yoga can improve thinking skills and daily function in adults with psychosis.

  Recruiting The Hong Kong Polytechnic University · Hung Hom, Kowloon · NCT07747181

• See if an early-detection program reduces time to treatment for first-episode psychosis

  We test whether a large, region-wide early-detection program can shorten the time from first psychotic symptoms to treatment and help people function better later.

  Recruiting at 2 sites Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital · Copenhagen, Denmark and 1 other locations · NCT07716969

• Cerebellar imaging markers to predict antipsychotic response in first-episode psychosis

  This will test whether cerebellar brain scans can predict how people with first-episode psychosis respond to 12 weeks of treatment with risperidone or aripiprazole.

  Recruiting Phase 4 Northwell Health · Glen Oaks, New York · NCT07483294

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.